Results 71 to 80 of about 1,973 (178)

Erratum to Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study (J Nephrol, 10.1007/s40620-014-0122-8)

, 2014
Background The recent multicenter, randomized, openlabel INDEPENDENT study demonstrated that sevelamer improves survival in new to hemodialysis (HD) patients compared with calcium carbonate.
Bell, Cynthia, Di Iorio, Biagio, Molony, Donald, RUSSO, DOMENICO, Cipriani, Filippo, Bellasi, Antonio, Ruggeri, Matteo   +6 more
core   +1 more source

Sevelamer Versus Calcium Carbonate in Incident Hemodialysis Patients: Results of an Open Label 24-Month Randomized Clinical Trial.

, 2013
Background: Whether the use of sevelamer rather than a calcium-containing phosphate binder improves cardiovascular (CV) survival in patients receiving dialysis remains to be elucidated.
A. Bellasi, B. Di Iorio, RUSSO, DOMENICO, D. Molony, E. Cucciniello, V. Bellizzi   +5 more
core   +1 more source

Calciphylaxis in the Upper GI Tract in an ESRD Patient: An Atypical Presentation and Review of Literature

Case Reports in Nephrology, Volume 2025, Issue 1, 2025.
Calciphylaxis, also referred to as calcific uremic arteriolopathy (CUA), is a rare and life‐threatening condition characterized by vascular calcification, ischemic tissue injury, and high morbidity and mortality. It is predominantly observed in patients with end‐stage renal disease (ESRD) who are undergoing dialysis and typically presents with painful ...
Pallavi D. Shirsat, Kunal Sonavane, Leonardo Ramirez Botana, Bharat Sachdeva, Poorani Gurumallesh   +4 more
wiley   +1 more source

Comparative Effectiveness of Phosphate Binders in Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis.

PLoS ONE, 2016
BackgroundChronic kidney disease-mineral and bone disorder (CKD-MBD) has been linked to poor health outcomes, including diminished quality and length of life. This condition is characterized by high phosphate levels and requires phosphate-lowering agents-
Nigar Sekercioglu, Lehana Thabane, Juan Pablo Díaz Martínez, Gihad Nesrallah, Christopher J Longo, Jason W Busse, Noori Akhtar-Danesh, Arnav Agarwal, Reem Al-Khalifah, Alfonso Iorio, Gordon H Guyatt   +10 more
doaj   +1 more source

Evaluation of Compliance With International Guidelines During the Follow‐Up of Hypoparathyroidism

International Journal of Endocrinology, Volume 2025, Issue 1, 2025.
Aims: Hypoparathyroidism is a disorder that causes renal complications, bone disease, an increased risk of cardiovascular diseases, neuromuscular complications, and ocular findings. In this study, we aimed to determine how well the existing guidelines were followed in the follow‐up of patients with hypoparathyroidism.
Beril Turan Erdogan, Sefika Burcak Polat, Caglar Keskin, Narin Nasiroglu İmga, Didem Ozdemir, Oya Topaloglu, Reyhan Ersoy, Bekir Cakir, Suraiya Saleem   +8 more
wiley   +1 more source

Effect of sevelamer on serum phosphorus levels in chronic kidney disease and hemodialysis patients; a systematic review and meta-analysis [PDF]

Journal of Nephropathology
Introduction: Hyperphosphatemia is an independent risk factor for mortality in chronic kidney disease (CKD) patients. Objectives: This systematic review and meta-analysis aimed to investigate the effect of Sevelamer on serum phosphorus levels in CKD and ...
Farshad Gharebakhshi, Mohammad Hossein Taklif, Arash Izadpanah Ghahremani, Mohamad Khaledi, Sara Abbasian, Seyedeh Mahsa Shariati Sough, Fatemeh Vashahi Torfi, Hamidreza Khodabandeh, Elnaz Hajian   +8 more
doaj   +1 more source

A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: Post hoc evaluation from a controlled, randomized study [PDF]

, 2013
Background Different phosphate binders exert differing effects on bone mineral metabolism and levels of regulating hormones. The objective of this post hoc evaluation of the CALcium acetate MAGnesium carbonate (CALMAG) study was to compare the effects of
Covic, Adrian Constantin, Kroczak, Mirostaw, Büschges Seraphin, Beatrix, Marzell, Barbara, Ghenu, Adrian, Ponce, Pedro, Martín de Francisco Hernández, Ángel Luis, Passlick Deetjen, Jutta   +7 more
core   +1 more source

Calcinosis cutis of the lower legs – hyperphosphatemic familial tumoral calcinosis in a patient with GALNT3 mutation

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 9, Page 1144-1146, September 2025.
David Ranzinger, Tobias Schaefer, Franziska Schauer, Kilian Eyerich, Anna Caroline Pilz   +4 more
wiley   +1 more source

In-vitro Equilibrium Phosphate Binding Study of Sevelamer Carbonate by UV-Vis Spectrophotometry

, 2018
Sevelamer carbonate is a cross-linked polymeric amine; it is the active ingredient in Renvela® tablets. US FDA provides recommendation for demonstrating bioequivalence for the development of a generic product of sevelamer carbonte using in-vitro ...
Uci Chilmi, Endah Sari, Theresia Kosasih, M. Syabani, Prawitasari Cahyaningsih, Budi Prasaja   +5 more
core   +1 more source

The Complexities and Challenges of Managing Genetic Causes of Hyperphosphataemia, a Case Report

Journal of Paediatrics and Child Health, Volume 61, Issue 8, Page 1332-1337, August 2025.
Farrah Rodrigues, Paul L. Hofman, Catherine Quinlan, Margaret Zacharin   +3 more
wiley   +1 more source